Literature DB >> 15284487

The reading frame BPLF1 of Epstein-Barr virus: a homologue of herpes simplex virus protein VP16.

Susanne Schmaus1, Hans Wolf, Fritz Schwarzmann.   

Abstract

The open reading frame BPLF1 of Epstein-Barr virus (EBV) shows homology to the Herpes simplex virus 1 (HSV1) protein VP16. This protein is a structural tegument component playing a pivotal role for HSV replication as trans-activator of viral immediate-early genes. An EBV gene with a comparable function has not been described so far. However, computer analysis indicated that BPLF1 may be a tegument protein homologous to VP16. This is the first report on the characterisation of the BPLF1 gene, its transcription, and expression of its gene product in vitro and in vivo. Using RT-PCR and Northern blot assays we demonstrated that the BPLF1 gene belongs to the class of late lytic cycle genes of EBV. Besides a full length transcript of 9.5 kb also a polyadenylated transcript of approximately 3 kb is synthesised. However, no consensus splice sites could be identified. Northern blot experiments using partially overlapping probes and sequencing of a BPLF1-specific cDNA revealed 1,550 nucleotides of the BPLF1 transcript, collinear in sequence with the viral genome from position 64547 to 66097. A recombinant Western blot assay detected BPLF1-specific antibodies in seropositive individuals, in particular in cases with elevated viral replication like infectious mononucleosis, chronic active infection, and nasopharyngeal carcinoma. This demonstrated expression of the BPLF1 protein in vivo. Thus, experimental data and computer analysis strongly support the hypothesis of BPLF1 being a tegument protein of the EBV homologous to VP16 of HSV1 and ORF22 of Varicella zoster virus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15284487     DOI: 10.1023/B:VIRU.0000036387.39937.9b

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  20 in total

1.  Replication of EBV in epithelial cells during infectious mononucleosis.

Authors:  S M Lemon; L M Hutt; J E Shaw; J L Li; J S Pagano
Journal:  Nature       Date:  1977-07-21       Impact factor: 49.962

2.  A functionally distinct TATA box required for late progression through the Epstein-Barr virus life cycle.

Authors:  T R Serio; N Cahill; M E Prout; G Miller
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

3.  EBV persistence in memory B cells in vivo.

Authors:  G J Babcock; L L Decker; M Volk; D A Thorley-Lawson
Journal:  Immunity       Date:  1998-09       Impact factor: 31.745

4.  Interdigitated residues within a small region of VP16 interact with Oct-1, HCF, and DNA.

Authors:  J S Lai; W Herr
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

5.  A single serine residue at position 375 of VP16 is critical for complex assembly with Oct-1 and HCF and is a target of phosphorylation by casein kinase II.

Authors:  D O'Reilly; O Hanscombe; P O'Hare
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

6.  Identification of herpes simplex virus DNA sequences which encode a trans-acting polypeptide responsible for stimulation of immediate early transcription.

Authors:  M E Campbell; J W Palfreyman; C M Preston
Journal:  J Mol Biol       Date:  1984-11-25       Impact factor: 5.469

7.  Epstein-Barr virus induction by a serum factor. I. Induction and cooperation with additional inducers.

Authors:  G Bauer; P Höfler; H Zur Hausen
Journal:  Virology       Date:  1982-08       Impact factor: 3.616

8.  A comparative study of human cell lines derived from patients with lymphoma, leukemia and infectious mononucleosis: membrane properties, ultrastructure, and surface morphology.

Authors:  H Ben-Bassat; A Polliack; S Mitrani-Rosenbaum; F Reichert; M Froimovici; N Goldblum
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

9.  Structural requirements in the herpes simplex virus type 1 transactivator Vmw65 for interaction with the cellular octamer-binding protein and target TAATGARAT sequences.

Authors:  R F Greaves; P O'Hare
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

10.  Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism.

Authors:  S Zalani; E Holley-Guthrie; S Kenney
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

View more
  8 in total

1.  The Epstein-Barr virus (EBV) deubiquitinating enzyme BPLF1 reduces EBV ribonucleotide reductase activity.

Authors:  Christopher B Whitehurst; Shunbin Ning; Gretchen L Bentz; Florent Dufour; Edward Gershburg; Julia Shackelford; Yves Langelier; Joseph S Pagano
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

2.  Bovine herpesvirus 1 productive infection stimulates inflammasome formation and caspase 1 activity.

Authors:  Jianlin Wang; Jeff Alexander; Matthew Wiebe; Clinton Jones
Journal:  Virus Res       Date:  2014-03-20       Impact factor: 3.303

3.  Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-κB signaling during productive replication.

Authors:  Shinichi Saito; Takayuki Murata; Teru Kanda; Hiroki Isomura; Yohei Narita; Atsuko Sugimoto; Daisuke Kawashima; Tatsuya Tsurumi
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

4.  Epstein-Barr virus genetic variation in lymphoblastoid cell lines derived from Kenyan pediatric population.

Authors:  Kenneth O Simbiri; Nicholas A Smith; Richard Otieno; Eric E M Wohlford; Ibrahim I Daud; Sumba P Odada; Frank Middleton; Rosemary Rochford
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

5.  Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice.

Authors:  Christopher B Whitehurst; Guangming Li; Stephanie A Montgomery; Nathan D Montgomery; Lishan Su; Joseph S Pagano
Journal:  mBio       Date:  2015-10-20       Impact factor: 7.867

6.  The Epstein-Barr Virus Immunoevasins BCRF1 and BPLF1 Are Expressed by a Mechanism Independent of the Canonical Late Pre-initiation Complex.

Authors:  Jessica McKenzie; Francesc Lopez-Giraldez; Henri-Jacques Delecluse; Ann Walsh; Ayman El-Guindy
Journal:  PLoS Pathog       Date:  2016-11-17       Impact factor: 6.823

Review 7.  Epstein-Barr Virus Hijacks DNA Damage Response Transducers to Orchestrate Its Life Cycle.

Authors:  Pok Man Hau; Sai Wah Tsao
Journal:  Viruses       Date:  2017-11-16       Impact factor: 5.048

8.  Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling.

Authors:  Michiel van Gent; Steven G E Braem; Annemieke de Jong; Nezira Delagic; Janneke G C Peeters; Ingrid G J Boer; Paul N Moynagh; Elisabeth Kremmer; Emmanuel J Wiertz; Huib Ovaa; Bryan D Griffin; Maaike E Ressing
Journal:  PLoS Pathog       Date:  2014-02-20       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.